| AFU | arbitrary fluorescence units |
| aiPLA2 | PLA2 activity of Prdx6 |
| ALI | acute lung injury |
| AngII | angiotensin II |
| AM | alveolar macrophage |
| BALf | bronchoalveolar lavage fluid |
| DFFDA | difluorofuorescein diacetate |
| DPPC | dipalmitoyl phosphatidylcholine |
| DUOX | dual oxidase |
| EC | endothelial cell |
| HRP | horseradish peroxidase |
| IT | intratracheal |
| IV | intravenous |
| LPA | lysophosphatidic acid |
| LPAR | LPA receptor |
| LPC | lysoPC |
| lysoPLD | lysophospholipase D |
| LPS | lipopolysaccharide |
| Marcks | myristoylated alanine-rich C kinase substrate protein |
| NOX | NADPH oxidase |
| PC | phosphatidylcholine |
| PG | phosphatidyl glycerol |
| PLA2 | phospholipase A2 |
| PIP | Prdx6-PLA2 inhibitory peptide |
| PMA | phorbol myristic acid |
| PMN | polymorphonuclear leokocyte; pPrdx6, phosphorylated Prdx6 |
| Prdx | peroxiredoxin |
| ROS | reactive O2 species |
| SP-A | surfactant protein A |
| TBARS | thiobarbituric reactive substances |
| WT | wild type |